Development of bacteria as diagnostics and therapeutics by genetic engineering

Citations

WEB OF SCIENCE

17
Citations

SCOPUS

23

초록

Bacteria sense and respond to the environment, communicate, and continuously interact with their surroundings, including host bodies. For more than a century, engineers have been trying to harness the natural ability of bacteria as live biotherapeutics for the treatment of diseases. Recent advances in synthetic biology facilitate the enlargement of the repertoire of genetic parts, tools, and devices that serve as a framework for biotherapy. This review describes bacterial species developed for specific diseases shown in in vitro studies and clinical stages. Here, we focus on drug delivery by programing bacteria and discuss the challenges for safety and improvement.

키워드

live biotherapy; drug delivery; synthetic biology; engineered bacteria; ATTENUATED SALMONELLA-TYPHIMURIUM; EXPRESSING MESOTHELIN CRS-207; MODIFIED LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; ORAL DELIVERY; BIOLOGICAL CONTAINMENT; SYNTHETIC BIOLOGY; GVAX PANCREAS; PHASE-I; E. COLI
제목
Development of bacteria as diagnostics and therapeutics by genetic engineering
저자
Lim, Daejin; Song, Miryoung
DOI
10.1007/s12275-019-9105-8
발행일
2019-08
유형
Review
저널명
Journal of Microbiology
권
57
호
8
페이지
637 ~ 643